Provided by Tiger Trade Technology Pte. Ltd.

Biogen

216.78
+2.431.13%
Post-market: 216.780.00000.00%19:30 EDT
Volume:722.35K
Turnover:156.95M
Market Cap:32.00B
PE:38.50
High:219.12
Open:217.76
Low:215.00
Close:214.35
52wk High:222.15
52wk Low:131.52
Shares:147.64M
Float Shares:147.31M
Volume Ratio:1.01
T/O Rate:0.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.63
EPS(LYR):8.79
ROE:4.58%
ROA:5.21%
PB:1.70
PE(LYR):24.66

Loading ...

How Investors Are Reacting To Biogen (BIIB) Raising EPS Guidance On Late-Stage Drug Trial Milestones

Simply Wall St.
·
8 hours ago

Biogen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Yesterday

Biogen Expands Autoimmune Pipeline With New Graves’ Disease Trial

TIPRANKS
·
Yesterday

Biogen Inc. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Aug 21

Insight Guru Says Health Care Dominates Mid-Cap 52-Week Highs List, with 11 of 19 Names at New Peaks

Reuters
·
Aug 20

Biogen Inc. Stock Underperforms Tuesday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Aug 19

Analysts Offer Insights on Healthcare Companies: Apogee Therapeutics (APGE) and Biogen (BIIB)

TIPRANKS
·
Aug 14

Wolfe Upgrades Biogen to Outperform From Peer Perform, Price Target is $300

MT Newswires Live
·
Aug 13

Barclays Keeps Their Hold Rating on Biogen (BIIB)

TIPRANKS
·
Aug 13

Biogen Files Form 3 Initial Beneficial Ownership Statement for Chief Legal Officer Michael Parini

Reuters
·
Aug 13

Biogen Inc. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Aug 12

Biogen’s Long-Term Spinraza Study Wraps Up, Setting the Stage for Key SMA Data

TIPRANKS
·
Aug 12

Global Drugmakers Invest Billions to Boost US Presence

Reuters
·
Aug 11

Kailera Therapeutics Names Nur Nicholson Chief Technology Officer

Reuters
·
Aug 11

Global Drugmakers Invest Billions to Boost US Presence

Reuters
·
Aug 10

Quantum BioPharma Receives United States FDA Clearance To Proceed with Lucid-MS Phase 2 Trial in Progressive Multiple Sclerosis:

GlobeNewswire
·
Aug 10

Should Biogen’s Profit Squeeze Amid Rising New-Therapy Sales Prompt Action From Biogen (BIIB) Investors?

Simply Wall St.
·
Aug 09

Insiders Shake Up General Dynamics, Thermo Fisher, Carvana, Biogen, Charles Schwab

TIPRANKS
·
Aug 08

Biogen completes acquisition of RayThera

TIPRANKS
·
Aug 07

Biogen Completes Acquisition of RayThera

Reuters
·
Aug 07